Advanced search
Publication Cover
Leukemia & Lymphoma Volume 46, 2005 - Issue 2
Submit an article Journal homepage
24
Views
3
CrossRef citations to date
0
Altmetric
Research Article

High-grade lymphoma after azathioprine treatment for Vogt-Kaganayi-Harada syndrome

Charmaine Hon Department of Ophthalmology Queen Mary Hospital, the University of Hong Kong Hong Kong
,
Shu-Leong Ho Department of Medicine Queen Mary Hospital, the University of Hong Kong Hong Kong
,
Edmond Ma Department of Pathology Queen Mary Hospital, the University of Hong Kong Hong Kong
,
Nigel Trendell-Smith Department of Pathology Queen Mary Hospital, the University of Hong Kong Hong Kong
&
Wing Au Department of Medicine Queen Mary Hospital, the University of Hong Kong Hong Kong
Pages 289-292 | Published online: 01 Jul 2009

REFERENCES

  • Kojima M, Nakamura S, Futamura N, Kurabayashi Y, Ban S, Itoh H, et al. Malignant lymphoma in patients with rheumatic diseases other than Sjogren's syndrome: a din-icopathologic study of five cases and a review of the Japanese literature. Jpn J Clin Once 1997;27(2):84–90.
  • Up Y, Irenic PH. Systemic lupus erythematosus and B-cell hematologic neoplasm. Lupus 2001;10(12):841— 850.
  • Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001;131(5):647 — 652.
  • Liang R, Chan D, Kwong YL, Chan V. Molecular detection of minimal residual disease for patients with leukaemia and lymphoma. Hong Kong Med J 1997;3(2):195 — 200.
  • Gocho K, Kondo I, Yamaki K. Identification of autoreactive T cells in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 2001;42(9):2004 — 2009.
  • Islam SM, Numaga J, Fujino Y, Hirata R, Matsuki K, Maeda H, et al. HLA class II genes in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 1994;35(11):3890–3896.
  • Rutzen AR, Ortega-Larrocea G, Schwab IR, Rao NA. Simultaneous onset of Vogt-Koyanagi-Harada syndrome in monozygotic twins. Am J Ophthalmol 1995;119(2):239–240.
  • Read RW. Vogt-Koyanagi-Harada disease. Ophthalmol Clin North Am 2002;15(3):333 — 341, vii.
  • Read RW, Rechodouni A, Butani N, Johnston R, LaBree LD, Smith RE, et al. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2001;131(5):599–606.
  • Federman DG, Kravetz JD, Ruser CB, Judson PH, Kirsner RS. Vogt-Koyanagi-Harada syndrome and ulcerative colitis. South Med J 2004;97(2):169— 171.
  • Najman-Vainer J, Levinson RD, Graves MC, Nguyen BT, Engstrom RE Jr, Holland GN. An association between Vogt-Koyanagi-Harada disease and Guillain-Barre syndrome. Am J Ophthalmol 2001;131(5):615–619.
  • Maruyama Y, Hayashi H, Takahashi K, lino K, Kora Y. A case of insulin dependent diabetes mellitus following systemic treatment for Vogt-Koyanagi-Harada syndrome. Ophthalmic Surg Lasers 2000;31(6):487 —490.
  • Jovic NS, Nesovic M, Vranjesevic DN, Ciric J, Marinkovic DM, Bonaci B. The Vogt-Koyanagi-Harada syndrome: association with autoimmune polyglandular syndrome type 1. Postgrad Med J 1996;72(850):495–497.
  • Chuah SY, Lyne AJ, Dronfield MW. Vogt-Koyanagi-Harada syndrome, a rare association of Hodgkin's disease. Postgrad Med J 1991;67(787):476–478.
  • Cipriani D, Landonio G, Canepari C. A case of Vogt-Koyanagi-Harada syndrome in a patient affected by Hodg-kin's disease. J Neurol 1989;236(5):303–304.
  • Walker J, Ober RR, Khan A, Yuen D, Rao NA. Intraocular lymphoma developing in a patient with Vogt-Koyanagi-Harada syndrome. Int Ophthalmol 1993;17(6):331 —336.
  • Sylvestre DL, Disston AR, Bui DP. Vogt-Koyanagi-Harada disease associated with interferon alpha-2b/ribavirin combi-nation therapy. J Viral Hepat 2003;10(6):467 — 470.
  • Pettitt AR, Neoh C, Wong SH, Clark RE. Vogt-Koyanagi-Harada syndrome complicating allogeneic bone marrow transplantation. Bone Marrow Transplant 1994;13(2):225 — 227.
  • Yato H, Matsumoto Y. CD56 + T cells in the peripheral blood of uveitis patients. Br J Ophthalmol 1999;83(12):1386— 1388.
  • Jaffe ES, Harris NL, Stein H, Vardiman ffe. Chapter 9: Immunodeficiency associated lymphoproliferative disorders. World Health Organization Classification of Tumors. Tu-mors of Haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. pp 251–271.
  • Au WY, Fung A, Man C, Ma SK, Wan TS, Liang R, et al. Aberrant p15 gene promoter methylation in therapy-related myelodysplastic syndrome and acute myeloid leukaemia: clinicopathological and karyotypic associations. Br J Haema-tol 2003;120(6):1062— 1065.
  • Leandro MJ, Isenberg DA. Rheumatic diseases and malig-nancy—is there an association? Scand J Rheumatol 2001;30(4):185— 188.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.